Document:

Exhibit 10.1

 

LOAN
AGREEMENT

NOW,
THEREFORE, for and in consideration of mutual premises provided or to be provided, 8 million dollars ($8,000,000) USD and other
good and valuable, sufficient, and equitable consideration, and mutual covenants, the receipt of, adequacy and sufficiency of which
is hereby acknowledged, exchanged, and satisfied by all and between all parties, and intending to be bound hereby the performance
thereof, and such represents reasonably just, equitable, adequate, and reasonable in value, the parties hereto covenant and agree
to and stipulate as follows. Each Party agrees that the fair value of consideration it is receiving, has received and will receive
under this Agreement equals or exceeds the fair value of the consideration it is delivering.

This
Loan Agreement supersedes all pervious term sheets and discussions and is the final documentation of the Parties’ undertakings
which is entered into and effective on the date of mutual execution hereof by and between:

Nemaura
Medical Inc., for itself, representatives, affiliates, and assigns, with an office located at Advanced technology Innovation
Centre, Oakwood Drive, Loughborough, LE11 3QF, United Kingdom, represents and warrants that they have the capacity and standing
to enter into this Agreement, hereinafter referred to as (“Borrower”);

 

		AND	

Carter
Gem Properties Limited, of Spyrou Kyprianou 47, 1st
Floor, Mesa Geitonia, 4004 Limassol, Cyprus, represents and warrants that they have the capacity and standing to enter into this
Agreement, hereinafter referred to as (“Lender”).

 

Borrower
and Lender are hereinafter sometimes individually referred to as a “Party” and collectively as the “Parties”.

SECTION
1 

		DEFINITIONS	

		1.	Defined Terms. As used
in this Agreement the following terms shall have the following meanings:

		a)	“Agreement” shall
mean this Loan Agreement, including any Exhibits or Schedules hereto, and as amended or supplemented from time to time, or as incorporated
by reference into subsequent agreements.

		b)	“Approved Loan Amount” shall
mean the maximum amount the Lender is willing to fund the Loan.

 

		c)	“Business Day” shall
mean the working day of a calendar week, except Saturday, Sunday and public holidays in accordance with relevant applicable laws.

		d)	“Breach” shall mean
any of the Events of Default specified in this Agreement and other Loan Documents that constitute a default unless specified otherwise.

 

    	1  

    	 

    

 

 

		e)	“Consideration” shall
mean Lender advising, coordinating, arranging, and consulting in the

structure
of this Agreement, sufficiency of which is hereby acknowledged. Consideration will include monetary and non-monetary exchanges,
services, and other covenants.

		f)	“Currency” the Loan
and all interest and fees shall be in United States Dollars (“USD”). Funds provided for in accordance with this agreement
must be paid in USD.

		g)	“Loan” means the loan provided
to Borrower hereunder.

		h)	“Loan Documents” shall
mean this Agreement and any other agreement made or delivered in conjunction with this Loan transaction.

		i)	“Loan Principal Amount” shall mean the total gross amount lent to Borrower by
Lender hereunder and subject to the stated conditions.

		j)	“Maturity Date” shall
have the meaning provided in Section 5.

		k)	“Term of the Loan” shall
mean the time period between the date that the Loan is provided to the Borrower the Maturity Date.

		2.	Use of Defined Terms. All
terms defined in this Agreement shall have such defined meanings when used herein and in any other Loan Documents.

		3.	Statements as to Knowledge.
Any statements, representations, or warranties which are based upon the knowledge of Borrower shall be deemed to have been made
after due inquiry with respect to the matter in question but without Borrower being required to seek an opinion of counsel with
respect thereto.

SECTION
2 MATERIAL TERMS OF THE LOAN 

		1.	Loan Principal Amount, drawdown, and repayment. 

		a)	Subject to all the terms and conditions of this Agreement, Lender agrees to lend to Borrower up
to EIGHT MILLION ($8,000,000.00) USD (“Approved
Loan Amount”).

		b)	The Loan will be drawn down in tranches, whereby the Borrower will provide 20 calendar days’
notice to the Lender and stipulating the amount of Loan to be drawn down. Lender will deposit the monies requested in the notice
from Borrower in the bank account as identified in schedule 1, within 20 calendar days of receipt of the notice.

		c)	Borrower will make repayments of interest on the Loan Principal Amount at quarterly intervals,
and the repayments shall be calculated according to the cumulative accrued loan at the end of each quarter. The repayment figure
shall be provided within 3 working days of the end of each quarter by the lender, and the repayment shall be made within 5 working
days of receipt of the repayment figure by the borrower.

 

    	  

    	 

    

 

 

		d)	Repayments shall be interest only and the Loan Principal Amount shall accrue and be repayable on
the Maturity Date.

		2.	Interest Rate. 

		a)	All outstanding Loan Principal Amounts shall bear interest at the rate of Eight
percent (8.0%) per year.

 

		b)	All interest due and payable hereunder shall be paid in or its value determined in U.S. dollars

		3.	Prepayment. The Loan may be
re-paid in full at any time, with 20 days’ notice without any penalty.

		4.	Fees

		a)	Loan Origination Fee. None.

		b)	Loan Maintenance Fee. None.

		c)	Third Party Expenses. Each
Party will be responsible for their costs associated with the execution of this Agreement.

		5.	Term of the Loan and Maturity Date of Loan.

		a)	The Loan shall mature, and the Loan Principal Amount shall be due and payable, on the fifth anniversary
of the date hereof (the “Maturity Date” or “Maturity”).

		b)	The Lender may extend the Maturity Date on the request of the Borrower. A fee in the amount of
one percent (1%) of the Loan Principal Amount (the “Extension Fee”)
shall be due and payable on the original Maturity Date if the Lender agrees to extend such Maturity Date at the prevailing annual
interest rate at the time of extension.

		c)	No later than sixty (60) calendar days prior to the Maturity Date, Borrower shall communicate to
Lender in writing whether it intends to repay the Loan Principal Amount on the Maturity Date. No later than thirty (30) calendar
days prior to the Maturity Date, Borrower shall provide proof of funds to repay the Loan Principal Amount.

SECTION
3

REPRESENTATIONS
AND WARRANTIES OF BORROWER 

Borrower
represents and warrants to Lender that:

 

1.
 Announcement. Borrower concedes that any regulatory announcement is the responsibility of the Borrower and Borrower
will comply with all requirements placed by securities regulatory authorities and any costs associated with such announcements
are the sole responsibility of the Borrower.

 

    	  

    	 

    

 

 

SECTION
4

REPRESENTATIONS
AND WARRANTIES OF LENDER

Lender
represents and warrants to Borrower that:

1.
 Loan Status. The loan is granted for use by the Borrower according to its business needs, and is not secured
on any assets of the business.

SECTION
5 

EVENTS
OF DEFAULT AND REMEDIES

1.
 Events of Default. An “Event of Default” shall exist if any term or condition of this Agreement is
breeched, including one or more of the following occurs: Failure by Borrower to pay the interest and all applicable fees or charges
when due or the Approved Loan Amount when due or any other default in the performance of an obligation that is not cured within
the applicable cure time of 5 business days.

SECTION
6

INDEMNITY
& LIMITATION OF LIABILITY

1.
Neither Party will be liable for any indirect, incidental, special, punitive, opportunity loss, or consequential damages, forgone
or speculative profit, including loss of revenue or profits or losses arising from its normal course of business.

SECTION
7 

		MISCELLANEOUS	

1.
 Notices. All notices and communications to either of the Parties by the other shall be in writing, sent
by government mail or by a reputable commercial carrier or electronically and shall be deemed duly given on the earlier of the
date the same is sent, if via electronic communication, or received when deposited in the mail, postage prepaid, as follows:

	
If to Lender:	 	 Carter
Gem Properties Limited, of

Spyrou Kyprianou 47, 1st
Floor, Mesa Geitonia, 4004

Limassol, Cyprus

E: Shoaib@cartergem.co.uk

	 	 	 
	If to Borrower: 	 	Nemaura
Medical Inc.,

Attention: K Farrar

Advanced Technology Centre

Oakwood Drive, Loughborough,
LE11 3QF, UK

E: kfarrar@nemaura.co.uk

	 	 	 

Either
Party may designate by notice in writing to the other a new address to which notices, requests, and other communications hereunder
shall be given.

Either
Party may designate by written notice to the other of a new bank account to which funds and payments are to be made.

 

    	  

    	 

    

 

 

		2.	Amendments. Amendments
to this Agreement (including the adding or updating of any annexes, appendices, or schedules) will not be enforced unless such
amendment is in writing and signed by authorized signatories on behalf of both Parties and added as an Addendum, with the exception
of either Party informing the other of change of banks and only notice of such change is sufficient. Email exchanges will not modify
this Agreement.

 

		3.	Assignment. This Agreement
may not be assigned by either Party without the prior written consent of the other Party.

		4.	Confidentiality. Other than as
may be required by applicable law, this Agreement is to be kept confidential and is not to be reproduced in any manner whatsoever
for persons other than the Parties hereto unless required by law. Specifically, each Party agrees to maintain the confidentiality
of the business, trade, finances, and methods (“Confidential Information”)
of the other Party and not disclose the Confidential Information to any person other than those whose knowledge is essential for
the performance of the Loan Documents. Lender will not reveal the existence of this Agreement to the media or any regulatory body
or government agency, unless ordered to do so by court of law or as required by applicable law. Lender may reveal the contents
of this agreement in order to defend Lender’s dignity and reputation and dispel incorrect public information about the subject
transaction.

		5.	Consideration. This transaction
and this Agreement constitute adequate and sufficient consideration and any argument for lack thereof is hereby waived. For purposes
of this clause, consideration will include Lender advising, coordinating, arranging, and consulting in the structure of this Agreement,
sufficiency of which is hereby acknowledged. Consideration will include monetary and non-monetary exchanges, services, and other
covenants.

		6.	Counterparts. This Agreement
may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same agreement.

		7.	Entire Agreement. This
Agreement contains the entire Agreement between the Parties hereto and is legally binding upon them as of the date of the execution
hereof. There will be no oral, written or electronic modifications other than written Addendums
executed by both Parties.

		8.	Force Majeure. Notwithstanding
any provision of this Agreement, neither Party shall be liable for its inability in performing any of its obligations hereunder
if such inability is caused by or arises as a result of circumstances beyond its reasonable control (“Force
Majeure Event”). For the purposes of this Clause, a Force Majeure Event shall include, without limitation, inability
or delay in performance caused through acts of God, fire, flood, riot, degradation in stock value, stock market crash, illiquidity
of the stock and other adverse financial market conditions, lightning, explosion, civil commotion, malicious damage, storm, tempest,
electronic malfunctions, acts or omissions of telecommunications carriers, acts of government or other regulatory authority, acts
or omissions of persons or bodies for whom the Party affected thereby is not responsible, and any other circumstances beyond the
reasonable control of the relevant Party. The Party affected by the Force Majeure Event shall promptly notify the other Party of
the estimated extent and duration of such inability to perform its obligations hereunder. This Agreement shall remain in force
until such time that the affected Party can perform.

		9.	Governing Law. This Agreement
and any dispute or claim arising out of or in connections with it, its subject matter, validity, formation or enforcement shall
be governed by and construed in accordance with the laws of the United Kingdom.

 

    	  

    	 

    

 

		10.	Severability. If any of
the provisions of this Agreement or in any of the Loan Documents is found by an arbitral tribunal and/or court of competent jurisdiction
to be unlawful, then such provision will be modified to reflect the commercial understanding between the Parties or, if impracticable,
is stricken out entirely as if it were never included in the first place and the remainder of the rights and obligations contained
in this Agreement or any of the Loan Documents shall continue to be in full force and effect.

		11.	Termination. Either Party
may terminate this agreement by giving 60 days’ notice to the other.

		12.	Waivers. No waiver of any
provision of this Agreement shall be effective unless agreed to in writing by the Parties. No course of dealing between Borrower
and Lender shall operate as a waiver of any of the rights of the Parties under this Agreement with the exception of an action for
injunctive relief, which shall not be permitted or attempted and shall be nullified upon application.

		13.	General Release and Waiver of Claims. For
consideration herein provided, Borrower hereby releases and forever discharges Lender and their respective successors, assigns,
partners, directors, officers, agents, attorneys, transferees, and employees from any and all claims, legal fees, demands, cross-actions,
controversies, causes of action, suits, damages, rights, liabilities and obligations, at law or in equity whatsoever, known or
unknown, whether past, present or future, now held, owned or possessed by Borrower, or which Borrower may, as a result of any actions
or inactions occurring prior to the execution of this Agreement.

IN
WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed as of the day and year written below.
It is specifically agreed and understood that this Agreement shall not be binding upon the Parties until the date it is signed
by Lender and Borrower, and that shall be the effective date of this Agreement.

END OF
TEXT

 

 

    	  

    	 

    

 

 

 

 

 

BORROWER:
Nemaura Medical Inc.,

 

Director or
Officer:

 

Signature:
/s/ Dewan F.H. Chowdhury

 

Date: 31st
July 2019

 

Witness:

Name:

Address:

 

 

 

Lender: Carter
Gem Properties Limited

 

Signature:
/s/ Sufyan Ismail

 

Date: 31st
July 2019

 

Witness:

Name:

Address:

 

 

    	  

    	 

    

 

 

 

EXHIBIT
1

BORROWER
BANKING INFORMATION: 

 

	Bank/Institution Name:	 
	Swift Code No/Routing No:	 
	Account Number:	 
	IBAN:	 
	Account Name:	 
	Bank Code:	 
	Branch Code:	 

 

III.
INTEREST, PRINCIPAL, & PAYMENT INFORMATION: 

Lender
Bank Information:

	Attention: 	 
	Bank Name: 	Deutsche Bank  
	A/C No. : 	13669290
	IBAN: 	CH2708659136692902001
	SWIFT: 	DEUTCHGG 
	
        Bank Address:
        Bank Code: 

        Branch Code 
	Place des Bergues 3, Case Postale, CH1211 GenevaExhibit

DESCRIPTION OF REGISTERED SECURITIES OF CIMPRESS N.V.

Our capital structure

Cimpress N.V.'s authorized share capital equals €2,000,000 and is divided in 100,000,000 ordinary shares, each with a nominal value of €0.01, and 100,000,000 preferred shares, each with a nominal value of €0.01. There are currently no preferred shares issued. 

Cimpress N.V. has registered its ordinary shares pursuant to Section 12(b) of the Securities Exchange Act.

Voting rights

Each of our ordinary shares is entitled to one vote. Resolutions of the general meeting of shareholders are adopted by a simple majority in a meeting in which at least one third of Cimpress' capital is represented, except where Dutch law or our articles of association provide for a special majority. 

According to our articles of association, the following decisions of the general meeting of shareholders require a majority of at least two-thirds of the votes cast, representing more than 50% of the issued share capital:
		
	•
	a resolution to cancel a binding nomination for the appointment of members of the Board of Directors

		
	•
	a resolution to appoint members of the Board of Directors in contravention of the list of nominees submitted by the Board

		
	•
	a resolution to dismiss or suspend members of the Board of Directors, other than pursuant to a proposal of the Board

In addition, our articles of association require a majority of at least two-thirds of the issued capital, if less than 50% of the issued share capital is represented for among other matters:
		
	•
	a resolution of the general meeting of shareholders regarding restricting and excluding pre-emptive rights, or decisions to designate the Board of Directors as the body authorized to exclude or restrict pre-emptive rights

		
	•
	a resolution of the general meeting of shareholders to reduce the outstanding share capital

		
	•
	a resolution of the general meeting of shareholders to merge or demerge

Pre-emptive rights

Without prejudice to the applicable legal provisions, upon the issue of ordinary shares for cash, each holder of ordinary shares has a pre-emptive right in proportion to the aggregate amount of ordinary shares held by him, her or it. The Board of Directors, if so authorized by the shareholders, may restrict or exclude shareholder pre-emptive rights. If the shareholders have not authorized the Board to restrict or exclude shareholder pre-emptive rights, then the general meeting of shareholders may itself vote to restrict or exclude pre-emptive rights, but only upon a proposal of the Board.

At our annual general meeting on November 13, 2018, our shareholders resolved to authorize the Board to restrict or exclude pre-emptive rights until May 13, 2020. 

Rotating terms of Board of Directors

The members of our Board of Directors serve for rotating terms of up to three years.

Anti-takeover Foundation

An independent foundation, Stichting Continuïteit Cimpress (the “Foundation”), was established to safeguard the interests of Cimpress and its stakeholders and to assist in maintaining our continuity and independence. On November 16, 2009, we entered into a Call Option Agreement (the "Call Option") with the Foundation pursuant to which the Foundation may acquire a number of our preferred shares up to a maximum of the total number of our ordinary shares then outstanding at an exercise price of €0.01 per share. The Call Option held by the Foundation is designed to provide a protective measure against unsolicited take-over bids for Cimpress or other hostile threats through the issuance of preferred shares to the Foundation that would give the Foundation voting and dispositive power over up to 50% of our outstanding securities.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]